IC5 Flashcards

1
Q

What cells produce MHC class I?

A

nucleated cells and platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What cells produce MHC class II?

A

APCs, B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What types of antigen does MHC class I bind to?

A

endogeneous: own, virus, neoantigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What types of antigen does MHC class II bind to?

A

exogenous: bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which MHC class binds to CD8+

A

class I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the process of antigen presentation by MHC I

A

endogeneous protein already in cytoplasm is broken down into peptides by proteasome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the process of antigen presentation by MHC II

A

exogeneous protein is phagocytosed into cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How have T cells adapted to produce intracellular signals despite a short cytoplasmic tail?

A

CD3 proteins form dimers- CDey, CDEs, CDzz that contain ITAMs. ITAMs contain tyr which are phosphorylated to initiate signal transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many CDRs are in T cells and antibodies

A

6 and 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How, when and where does hypervariability of CDRs occurs in B cells?

A

In bone marrow, naive B cells undergo genetic rearrangement of variable domain ->clones are different

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How, when and where does hypervariability of CDRs occurs in T cells?

A

Naive T cells in thymus undergo genetic recombination in variable domains. Va undergoes VJ recombination while VB undergoes DJ and then VDJ recombination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Whats the difference between monoclonal and polyclonal antibodies?

A

Monoclonal ab produced from the same B cell clone and only recognises one epitope.
polyclonal ab is a mixture of monoclonal ab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are polyclonal antibodies made?

A

from passive immunisation of animals and collecting their antiserum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What 2 ways is antiserum purified? Which purification method results in the isolation of more antigen-specific antibodies

A

proteins A/G and
Immunoaffinity column chromatography. The latter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What modification is done in chimeric mabs?

A

all seq humanised except V domains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What modification is done in humanised mabs?

A

all seq humanised except CDR domains

17
Q

Is humanised mabs or recombinant human mabs 100% human?

A

recombinant human mabs

18
Q

What is a bispecific antibody derivative?

A

to different Fab arms

19
Q

Whats the different between bispecific and triomabs antibody derivatives?

A

triomab is a bispecific + Fc component

20
Q

How are Fab2 and Fab antibody derivatives made?

A

pepsin and papain enzymes to cleave ab

21
Q

What does defucosylating an antibody do?

A

enhance affinity for Fc receptor on effector cells to bind to antigen

22
Q

Which T cell therapeutic doesn’t involve genetic modification?

A

TIL

23
Q

Which generation of CAR-T effective against antigen negative tumour cells?

A

4th gen as it has a transgene that secretes IL2 cytokine after antigen binding to scfv which activates endogeneous T cells which can recognise that antigen CAR-T cannot.

24
Q

What are the upgrades in the different generations of CAR-T? and what difference does it make?

A
  1. CD3z
    • CD28
    • 4-BB
    • transgene
      stronger signaling and more potent antitumor activity
25
Q

Is TCR-T or CAR-T more effective in cancer treatment? Why?

A

TCR complex allows full activation at low antigen concentration and extended killing

26
Q

Which T cell immunotherapy is used in both solid and hematological tumours?

A

TCR-T

27
Q

Which T cell immunotherapy induces more CRS cytokine release syndrome? CAR-T or TCR-T

A

CAR-T

28
Q

What do immune checkpoint inhibitors do?

A

they bind to checkpoint targets so that endogeneous ligand cannot bind to it and immune suppression is prevented

29
Q

What are the 3 types of cancer vaccines?

A

cell, protein/peptides, nucleic acid

30
Q

why are protein/peptide cancer vaccines less effective?

A
  1. neoantigens not included in vaccine
  2. peptides are too small ->non-specific binding + can only bind to MHC I
31
Q

What is anergy?

A

lack of immune response

32
Q

What type of nucleic acid is preferred in cancer vaccines?

A

RNA as its immediately translated and does not involve insertion into host DNA. so there is no chance of insertional mutation.

33
Q
A